Amarin Corp (AMRN)

• Market cap: $310M
• 1 day: 2.18%
• 5 days: -3.98%
• 1 month: -7.71%
• 3 months: 39.13%
• 6 months: 28.72%
• Year to date: 42.98%
• 1 year: -4.35%
• 5 years: -88.64%
• 10 years: -65.98%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Employees: 275

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

1,175% more call options, than puts

Call options by funds: $153K | Put options by funds: $12K

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

0.43% less ownership

Funds ownership: 17.23% [Q4 2024] → 16.8% (-0.43%) [Q1 2025]

10% less capital invested

Capital invested by funds: $34.4M [Q4 2024] → $31.1M (-$3.3M) [Q1 2025]

12% less funds holding

Funds holding: 161 [Q4 2024] → 141 (-20) [Q1 2025]

26% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 38

56% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 27

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $12 20% downside
• Avg. target: $12 20% downside
• High target: $12 20% downside

1 analyst rating

• positive: 0 0%
• neutral: 0 0%
• negative: 1 100%

Goldman Sachs Paul Choi

20% downside $12

Sell Maintained

25 Jun 2025